Biological Safety of Camel Milk After Albendazole and Ivermectin Treatment.

The problem of Albendazole and Ivermectin medicine residues in milk is a current question in food safety. With no data being available, the present study aimed to assess the risk of antiparasitic residues in camel milk after injection at curative dose. For the experiment, 10 camels were allocated to two groups, treated with Albendazole and Ivermectin, respectively; milk samples were taken every day for the first 4 days, then approximately every 2 weeks for 6 months. In addition, blood samples were taken for the Albendazole group. The samples were analysed by HPLC. On average, for Albendazole, the maximum concentration appeared on day 2 (52 ± 65.2 µg/mL) and day 48 (50 ± 63.1 µg/mL). After 210 days, the residues remained at around 11 µg/mL (MRL = 0.1 µg/mL). The kinetic assessment in the blood samples showed a slight shift in relation to that of milk during the first days of the experiment, but there was no significant difference between them. For Ivermectin, only one peak appeared on day 101 (0,96 ± 1,19 µg/mL), and after 172 days, the mean concentration was still 0.12 µg/mL (MRL = 0.01 µg/mL). The persistence of the residues for a long time after injection leads us to consider that specific guidelines should be proposed for ensuring the safety of camel milk.